Allogeneic fibroblast cell therapy in the treatment of recessive dystrophic epidermolysis bullosa
暂无分享,去创建一个
A. Kubanov | V. V. Chikin | V. Albanova | A. Karamova | M. Nefedova | E. Monchakovskaya | V. Smoliannikova | V. Chikin
[1] J. McGrath,et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines , 2016, The British journal of dermatology.
[2] E. Bauer,et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. , 2014, Journal of the American Academy of Dermatology.
[3] J. McGrath,et al. Cell therapy in dermatology. , 2014, Cold Spring Harbor perspectives in medicine.
[4] D. Murrell,et al. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. , 2013, Journal of the American Academy of Dermatology.
[5] L. Bruckner-Tuderman,et al. Collagen VII plays a dual role in wound healing. , 2013, The Journal of clinical investigation.
[6] J. McGrath,et al. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. , 2011, The Journal of investigative dermatology.
[7] D. Murrell,et al. Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa. , 2010, Dermatologic clinics.
[8] O. Paul,et al. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] J. McGrath,et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. , 2008, The Journal of investigative dermatology.
[10] T. Bley,et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. , 2008, The Journal of clinical investigation.
[11] M. Akiyama,et al. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. , 2006, The Journal of investigative dermatology.
[12] Mei Chen,et al. Fibroblasts as target cells for DEB gene therapy. , 2006, The Journal of investigative dermatology.
[13] H. Nagai,et al. The early influence of albumin administration on protein metabolism and wound healing in burned rats , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[14] D. Keene,et al. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. , 2003, The Journal of investigative dermatology.